254 related articles for article (PubMed ID: 16412852)
41. [Neoangiogenesis and coronary atherosclerosis: diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease].
Shevchenko AO; Shevchenko OP; Orlova OV; Tulikov MV
Kardiologiia; 2006; 46(11):9-15. PubMed ID: 17159877
[TBL] [Abstract][Full Text] [Related]
42. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
[TBL] [Abstract][Full Text] [Related]
43. A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
James SK; Lindahl B; Armstrong P; Califf R; Simoons ML; Venge P; Wallentin L;
Int J Cardiol; 2004 Feb; 93(2-3):113-20. PubMed ID: 14975536
[TBL] [Abstract][Full Text] [Related]
44. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
[TBL] [Abstract][Full Text] [Related]
46. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
[TBL] [Abstract][Full Text] [Related]
48. Relationship between serum vasoactive factors and plaque morphology in patients with non-ST-segment elevated acute coronary syndrome.
Lu YF; Lü SZ; Chen YD
Chin Med J (Engl); 2010 Jan; 123(2):193-7. PubMed ID: 20137369
[TBL] [Abstract][Full Text] [Related]
49. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.
Ndrepepa G; Berger PB; Mehilli J; Seyfarth M; Neumann FJ; Schömig A; Kastrati A
J Am Coll Cardiol; 2008 Feb; 51(7):690-7. PubMed ID: 18279731
[TBL] [Abstract][Full Text] [Related]
50. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
[TBL] [Abstract][Full Text] [Related]
51. Soluble CD40 ligand in acute coronary syndromes.
Kritharides L; Lau GT; Freedman B
N Engl J Med; 2003 Jun; 348(25):2575-7; author reply 2575-7. PubMed ID: 12815146
[No Abstract] [Full Text] [Related]
52. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
[TBL] [Abstract][Full Text] [Related]
53. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
Valgimigli M; Campo G; Arcozzi C; Malagutti P; Carletti R; Ferrari F; Barbieri D; Parrinello G; Percoco G; Ferrari R
J Am Coll Cardiol; 2007 Jul; 50(2):138-45. PubMed ID: 17616297
[TBL] [Abstract][Full Text] [Related]
54. Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent.
Steppich BA; Kaufmann J; Sepp D; Kunert K; Rutz T; Stratz C; Ott I
Coron Artery Dis; 2009 Mar; 20(2):130-7. PubMed ID: 19293668
[TBL] [Abstract][Full Text] [Related]
55. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
Exaire JE; Fathi RB; Brener SJ; Karha J; Ellis SG; Bhatt DL
Arch Cardiol Mex; 2006; 76(4):376-82. PubMed ID: 17315613
[TBL] [Abstract][Full Text] [Related]
56. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
[TBL] [Abstract][Full Text] [Related]
58. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.
Kandzari DE; Hasselblad V; Tcheng JE; Stone GW; Califf RM; Kastrati A; Neumann FJ; Brener SJ; Montalescot G; Kong DF; Harrington RA
Am Heart J; 2004 Mar; 147(3):457-62. PubMed ID: 14999194
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of preoperative cardiac troponin I in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
Thielmann M; Massoudy P; Neuhäuser M; Knipp S; Kamler M; Piotrowski J; Mann K; Jakob H
Chest; 2005 Nov; 128(5):3526-36. PubMed ID: 16304309
[TBL] [Abstract][Full Text] [Related]
60. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
Galli M; Maggioni AP; Vassanelli C; Tavazzi L
Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
